Skip to main content
    C

    CEL-SCI Corp (CVM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.66
    +0.38 (+29.69%)

    Market Cap: $22.51M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    CEL-SCI Corp (CVM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to CEL-SCI are Evaxion Biotech AS (EVAX), NextCure (NXTC) and Celularity (CELU). By market cap, CEL-SCI ranks 8th of the 13 companies on this page; Elicio Therapeutics (ELTX) is the largest at $42.46M.

    Peer Comparison

    CVM's ROIC of -109.0% is below the peer median of -96.6%, and its revenue growth of -62.7% is below the median of -4.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    CEL-SCI (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    Evaxion Biotech AS (EVAX)$25.27MN/A0.2x-115.5%-79.5%-100.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Celularity Inc (CELU)$20.45MN/A1.0x-245.7%N/A-5.3%0.00%
    Lite Strategy, Inc. (LITS)$25.30MN/AN/A0.0%N/A0.0%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    Elicio Therapeutics Inc. (ELTX)$42.46MN/AN/A0.0%-96.6%0.0%0.00%
    Cocrystal Pharma Inc (COCP)$18.88MN/A39.2x0.0%N/A26.9%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Peer median$25.29MN/A1.5x0.0%-96.6%-4.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to CEL-SCI, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Evaxion Biotech AS (EVAX)
    Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company...
    EVAX competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Celularity Inc (CELU)
    Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta.
    CELU competitors
    Lite Strategy, Inc. (LITS)
    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
    LITS competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    Elicio Therapeutics Inc. (ELTX)
    Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment.
    ELTX competitors
    Cocrystal Pharma Inc (COCP)
    Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic...
    COCP competitors
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors

    Frequently Asked Questions About CVM

    Who are CEL-SCI's main competitors?

    The companies most similar to CEL-SCI include Evaxion Biotech AS (EVAX), NextCure (NXTC), Celularity (CELU), Lite Strategy (LITS) and Estrella Immunopharma (ESLA), listed from the closest match.

    Who is CEL-SCI's biggest competitor?

    Elicio Therapeutics (ELTX) is the largest of the similar companies at $42.46M; Evaxion Biotech AS (EVAX) is the closest match by business profile, size, sector and industry.

    How does CVM stock compare with its competitors?

    CVM's net margin is 0.0% against a peer median of 0.0%.

    Which of CEL-SCI's competitors pays a higher dividend?

    CEL-SCI pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is CEL-SCI bigger than its competitors?

    No. CEL-SCI is 8th by market cap among the 13 companies on this page; the largest is Elicio Therapeutics (ELTX) at $42.46M.